IGLC2 and colorectal carcinoma: We also identified the association of IgA+IGLC2+ plasma cells with poor CRC prognosis, and demonstrated a significant interaction between B‐cell and myeloid‐cell signaling, and found CCL8+ cycling B cells/CCR5+ T‐cell interactions as a potential antitumoral mechanism in advanced CRC tumors.